Mechanism of growth inhibitory effect of cape aloe extract in Ehrlich ascites tumor cells

Journal of Nutritional Science and Vitaminology

Volumn 53, Issue 6, 2007, Pages 540-546

  Kametani, Saeda ^a,c   Oikawa, Tomoko ^a   Kojima Yuasa, Akiko ^a   Kennedy, David Opare ^b   Norikura, Toshio ^a   Honzawa, Mayumi ^c   Matsui Yuasa, Isao ^a  

^a Osaka City University   (Japan)

^b Mailman School of Public Health   (United States)

^c HYOGO UNIVERSITY   (Japan)

Author keywords

Cape aloe (Aloe ferox Miller); Cell cycle; Ehrlich ascites tumor cells; Retinoblastoma protein

Indexed keywords

CAPE ALOE EXTRACT; DICHLOROMETHANE; PLANT EXTRACT; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; DNA SYNTHESIS; DOSE RESPONSE; DRUG MECHANISM; EHRLICH ASCITES TUMOR; EMBRYO; EMBRYO CELL; FIBROBLAST; MOUSE; NONHUMAN;

ALOE; ANIMALS; CARCINOMA, EHRLICH TUMOR; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; G1 PHASE; G2 PHASE; GROWTH INHIBITORS; MICE; NIH 3T3 CELLS; PHOSPHORYLATION; PLANT EXTRACTS; RETINOBLASTOMA PROTEIN; S PHASE;

ALOE FEROX; BACTERIA (MICROORGANISMS);

EID: 38549095476     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.53.540     Document Type: Article

References (33)

1. Lippman SM, Benner SE, Hong WK. 1994. Cancer hemoprevention. J Clin Oncol 12: 851-873.
2. Quasney ME, Carter LC, Oxford C, Watkins SM, Gershwin ME, German JB. 2001. Inhibition of proliferation and induction of apoptosis in SNU-1 human gastric cancer cells by the plant sulfolipid, sulfoquinovosyldiacylglycerol. J Nutr Biochem 12: 310-315.
3. Tapsell LC, Hemphill I, Cobiac L, Patch CS, Sullivan DR, Fenech M, Roodenrys S, Keogh JB, Clifton PM, Williams PG, Fazio VA, Inge KE. 2006. Health benefits of herbs and spices: the past, the present, the future. Med J Aust 185: S4-24.
4. Pal S, Choudhuri T, Chattopadhyay S, Bhattacharya A, Datta GK, Das T, Sa G. 2001. Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells. Biochem Biophys Res Commun 288: 658-665.
5. Kennedy DO, Kojima A, Hasuma T, Yano Y, Otani S, Matsui-Yuasa I. 2001. Growth inhibitory effect of green tea extract and (-)-epigallocatechin in Ehrlich ascites tumor cells involves a cellular thiol-dependent activation of mitogenic-activated protein kinases. Chem Biol Interact. 134: 113-133.
6. Arimura T, Kojima-Yuasa A, Watanabe S, Suzuki M, Kennedy DO, Matsui-Yuasa I. 2003. Role of intracellular reactive oxygen species and mitochondrial dysfunction in evening primrose extract-induced apoptosis in Ehrlich ascites tumor cells. Chem Biol Interact 145: 337-347.
7. Kametani S, Matsui-Yuasa I, Kojima-Yuasa A, Arimura T, Kennedy DO, Honzawa M, Kikuzaki H, Nakatani N. 2004. Screening of spice and herb extracts for cytotoxic activity against Ehrlich acites tumor cells and DPPH radical scavenging activity. ITE Lett 5: 67-75.
8. Yagi A. 2004. Bioactivity of Aloe arborescens preparations. In: Aloes (Reynolds T, ed), p 333-351. CRC Press, Florida.
9. Mapp RK, McCarthy TJ. 1970. The assessment of purgative principles in aloes. Planta Med 18: 361-365.
10. van Wyk BE, Wink M. 2004. Medicinal Plant of the World, p 40. Timber Press, Oregon.
11. Newton LE. 2004. Aloes in habitat. In: Aloes (Reynolds T, ed), p 3-14. CRC Press, Florida.
12. Ishii Y, Tanizawa H, Takino Y. 1988. Studies of aloe. II. Mechanism of cathartic effect. Yakugaku Zasshi 108: 904-910 (in Japanese).
13. Speranza G, Morelli CF, Tubaro A, Altinier G, Duri L, Manitto P. 2005. Aloeresin I, an anti-inflammatory 5-methylchromone from cape aloe. Planta Med 71: 79-81.
14. Soeda M, Otomo M, Ome M, Kawashima K. 1966. Studies on anti-bacterial and anti-fungal activities of Cape aloe. Nippon Saikingaku Zasshi 21: 609-614 (in Japanese).
15. Norikura T, Kennedy DO, Nyarko AK, Kojima A, Matsui-Yuasa I. 2002. Protective effect of aloe extract against the cytotoxicity of 1,4-naphthoquinone in isolated rat hepatocytes involves modulations in cellular thiol levels. Pharmacol Toxicol 90: 278-284.
16. Kennedy DO, Matsumoto M, Kojima A, Matsui-Yuasa I. 1999. Cellular thiols status and cell death in the effect of green tea polyphenols in Ehrlich ascites tumor cells. Chem Biol Interact 122: 59-71.
17. Zhang SZ, Lipsky MM, Trump BF, Hsu IC. 1990. Neutral red (NR) assay for cell viability and xenobiotic-induced cytotoxicity in primary cultures of human and rat hepatocytes. Cell Biol Toxicol 6: 219-234.
18. Kennedy DO, Kojima A, Moffatt J, Yamagiwa H, Yano Y, Hasuma T, Otani S, Matsui-Yuasa I. 2002. Cellular thiol status-dependent inhibition of tumor cell growth via modulation of retinoblastoma protein phosphorylation by (-)-epigallocatechin. Cancer Lett 179: 25-32.
19. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
20. Sherr CJ, Roberts JM. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163.
21. Kawada M, Kuwahara A, Nishikiori T, Mizuno S, Uehara Y. 1999. NA22598, a novel antitumor compound, reduces cyclin D1 levels, arrests cell cycle at G1 phase, and inhibits anchorage-independent growth of human tumor cells. Exp Cell Res 249: 240-247.
22. Riley DJ, Lee EY, Lee WH. 1994. The retinoblastoma protein: more than a tumor suppressor. Annu Rev Cell Biol 10: 1-29.
23. Sambucetti LC, Fischer DD, Zabludoff S, Kwon PO, Chamberlin H, Trogani N, Xu H, Cohen D. 1999. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J Biol Chem 274: 34940-34947.
24. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
25. Shan BE, Zeki K, Sugiura T, Yoshida Y, Yamashita U. 2000. Chinese medicinal herb, Acanthopanax gracilistylus, extract induces cell cycle arrest of human tumor cells in vitro. Jpn J Cancer Res 91: 383-389.
26. Manitto P, Speranza G, De Tommasi N, Ortoleva E, Manitto P. 2003. Aloeresin H, a new polyketaide constituent of cape aloe. Tetrahedron 59: 401-408.
27. Speranza G, Manitto P, Monti D, Lianza F. 1993. Feralolide, a dihydroisocoumarin from cape aloe. Phytochemistry 33: 175-178.
28. Speranza G, Manitto P, Monti D, Lianza F. 1990. Feroxidin, a novel 1-methyltetralin derivative isolated from cape aloe. Tetrahedron Lett 31: 3077-3080.
29. van Gorkom BA, Timmer-Bosscha H, de Jong S, van der Kolk DM, Kleibeuker JH, de Vries EG. 2002. Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1. Br J Cancer 86: 1494-1500.
30. Lee HZ, Hsu SL, Liu MC, Wu CH. 2001. Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma. Eur J Pharmacol 431: 287-295.
31. Pecere T, Gazzola MV, Mucignat C, Parolin C, Vecchia FD, Cavaggioni A, Basso G, Diaspro A, Salvato B, Carli M, Palu G. 2000. Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res 60: 2800-2284.
32. Kuo PL, Lin TC, Lin CC. 2002. The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sci 71: 1879-1892.
33. Chen HC, Hsieh WT, Chang WC, Chung JG. 2004. Aloe-emodin induced in vitro G2/M arrest of cell cycle in human promyelocytic leukemia HL-60 cells. Food Chem Toxicol 42: 1251-1257.